top of page

Welcome to Broadline Capital 



Founded 18 years ago, Broadline Capital is a global alternative investment firm primarily focused on growth capital, impact investments, and late-stage companies expecting a near-term exit such as an IPO or M&A event. At Broadline, we are inspired by champions — people of vision and courage — whose ideas can positively change the world, and who are ready to transform their business into the next big, industry-changing company.


When evaluating opportunities, we seek category leaders and category creators that are positioned to create broad impact as the world continues to transition toward an economy increasingly driven by the pursuit of a Healthier, more Efficient, and more Sustainable way of life. We invest in purpose-driven companies that are reshaping their industry and whose Addressable Market is large enough to represent a promising commercial opportunity. We prefer teams who have designed a clear plan to create exceptional value for all key stakeholders of the company  including shareholders, contributing team members, suppliers, customers, neighbors, and society...and we seek companies that have the right team in place to execute and capture the full opportunity.


Broadline's principals have spent their entire careers building trust-based relationships globally. They have launched and developed successful companies, negotiated quality exits on behalf of themselves and their investors, and led some of the most creative deals in the history of their category. Our access to domain expertise, our pragmatic operating experience, and our vast network of relationships built over many years combine to help support our Broadline-sponsored deals. We believe our current opportunities are among the most exciting on the planet.

Learn why -


New York    |    Miami    |    San Diego    |    Boulder    |    Columbus    |    Seoul    |    Shanghai    |    London


 Our Approach 

Broadline's proprietary investment process is designed to stretch alpha at every link of the investment value chain. We seek diversification across a range of industries, geographies, transaction structures, and market capitalizations. When selecting opportunities, we take a two-pronged approach:

  • First, we start with a "Top-Down" view to choose thematic categories that are positioned to grow and create broad impact as the world continues to transition toward an economy increasingly driven by the pursuit of a healthier, more efficient, and more sustainable way of life. 

  • Next, we take a "Bottom-Up" view to selectively identify category leaders and category creators that focus on a large addressable market where Broadline has access to relevant domain expertise. We place emphasis on companies that are projected to be nearing a liquidity event such as an IPO and have a management team in place with the capability to capture the full opportunity.  


  Portfolio Highlights  

 We place emphasis on 5 Thematic Areas of Focus:

  • Electrification of Everything. Batteries, Electric Powertrains, and Charging Infrastructure enabling the "Electrification of Everything" from Industrial Equipment to Commercial Trucks, Aircraft, and Watercraft

  • Purpose-driven Technologies.  Creative business models that provide broad access to unprecedented efficiencies through AI, SaaS, Robotics, Business Process Automation, 5G WiFi, and Low Earth Orbit (LEO) Satellites

  • Financial Services.  FinTech and DeFi solutions that unlock value through digital products and services that are Smarter, Faster, and More Accessible.

  • Healthcare.  Innovative platforms based on AI, SynBio, and non-invasive devices that show promising potential for improved patient safety and clinical outcomes.

  • Food System.  Agritech, Smart Vertical Greenhouse Technologies, and delivery solutions that improve Food Safety, Traceability, Production Efficiency, and Supply Chain Resilience.

We invite you to scroll through case examples below. If you are a Broadline registered investor, please click on the "Investor Login" tab at the top of this website for recent management reports from current portfolio companies.

Invest Examples


EndoSphere logo.jpeg

ENDOSCOPIC Medical Devices

EndoSphere is a medical technology company that has developed a first-in-class, less-invasive medical device platform to treat metabolic diseases, including some of the world's largest healthcare issues such as Obesity, Type 2 Diabetes, and Fatty Liver Disease. EndoSphere's novel "Endo-Metabolic" device platform represents a completely new category of devices that is the first to uniquely focus on the Duodenum, the upper intestinal organ that is widely recognized as the body's metabolic control center.  Endosphere's flagship anti-obesity device is incisionless, reversible and repeatable. In clinical studies, the device enabled Obese patients to achieve significant Excess Weight Loss (EWL) without the need for more invasive alternatives. Unlike restrictive devices and bariatric surgeries, which typically work against nature, EndoSphere's "Endo-Metabolic" devices work with the body by amplifying its physiological responses to food intake in order to help accelerate satiation, recalibrate brain-gut metabolic feedback loops, recalibrate hormones, and rebalance insulin levels. EndoSphere's patent asset portfolio is 100% company-owned and free from any third-party licensing or royalty obligations. EndoSphere has received numerous industry recognitions, including the industry's "Fierce15" award, named by FierceBiotech, which annually recognizes the world's most promising privately-held medical innovations. The original version of its anti-obesity device received CE Mark (regulatory approval in 31 countries), and an enhanced version has entered clinical stages of development. For more information, visit

Batteries and e-Powertrains


Carbon-Free Lithium-ion and Solid State BatterY CATHODES

Powermers has created the world's first Carbon-Free Cathodes for lithium-ion and solid state batteries. They did it by replacing "inactive/deadweight" material (carbon, binders and solvents) with proprietary conductive polymers. Powermers' transition-metal polymers demonstrate higher catalytic functionality than pure noble-metal catalysts (including gold, platinum, and palladium). Their differentiated results in Safety and Energy Capacity are documented in industry peer-review publications including American Chemical Society's Applied Materials & Interfaces. 5 measurable advantages have been Independently validated by U.S. Army Corps of Engineers (CERL) and universities around the world including the Center for Automotive Research at The Ohio State University (O.S.U. C.A.R.). For more information, please visit

 - Safer:  Our simplified cathode increases Safety and Stability by reducing Thermal Runaway Risk (cause of most high-voltage lithium-ion battery combustion).

 - Less Toxic: Reduces reliance on Toxic Solvents.

 - Higher Energy: Expands the Active Material Limit, increasing Energy without sacrificing Power, Cycle Life, Weight, or Cost per KWH.

 - Drop-in Replacement:  Enables ease of adoption into established battery manufacturing processes.

 - Reduced Cost per KWH Total Cost per KWH is also enabled by the decreased reliance on costly toxic solvents. 



 Our Team 


We are excited about the collegial team of professionals that form Broadline Capital. Our investment leaders have spent their entire careers building trust-based relationships globally, and have led some of the most creative deals in the history of their categories. They understand what it takes to align multiple stakeholders toward a shared vision and develop a successful business, because they've done it.  At Broadline, we love going back to our roots by collaborating with management teams that are highly credible, focused, and inspired to achieve a shared vision. 


Our investment leaders are past CEOs and entrepreneurs whose prior companies created significant value and achieved quality exits on behalf of themselves and their investors. They've excelled in prior careers at top firms such as McKinsey & Company, Morgan Stanley, General Electric, Allergan, Apple, Brunswick, Oppenheimer Capital, Pfizer, PwC, and Roche. Before that, they received training at recognized educational institutions, collectively earning 46 degrees — including 21 advanced degrees and 11 doctorates — in programs at Columbia, Harvard, Howard, Johns Hopkins, Kellogg, Leeds School of Business, McGill, The Ohio State University, Princeton, and Stanford. The collective experience and relationships of our team enable Broadline to contribute unique value beyond capital for Broadline-backed companies.  

Morgan Stanley logo.png


"At Broadline Capital, we are inspired by champions – people of vision and courage – whose ideas can positively change the world, and who are working to transform their ideas into the next big, industry-changing company." 


If you share our perspective, we invite you to join us...We look forward to hearing from you.



80 SW 8th St., 20th Floor

Miami, FL 33130

Broadline® is a Registered Trademark.

Copyright © Broadline Capital LLC 2005-2023.

All Rights Reserved.

bottom of page